The aim of our study was to analyze the link between neuroblastoma risk factors and prognosis in pediatric patients and to see if there is an association between IDRF and other prognostic factors such as age, MYCN status, NSE value and tumor size. The gene discussed is ENO2; the disease is neoplasm.